AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2026)

AdaptHealth has reported Current Deferred Revenue for 9 years, with the latest figure at $64.7 million in Q2 2026.

• On a quarterly basis, Current Deferred Revenue rose 15.02% year-over-year to $64.7 million in Q2 2026; TTM through Jun 2026 was $64.7 million, a 15.02% increase from a year earlier, with the FY2025 full-year figure at $59.3 million, up 69.81% from the prior year.
• Current Deferred Revenue was $64.7 million for Q2 2026 at AdaptHealth, up from $59.7 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $64.7 million in Q2 2026, with the low at $30.6 million in Q1 2022.
• Average Current Deferred Revenue over 5 years is $42.6 million, with a median of $36.0 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Current Deferred Revenue fell 25.3% in 2024, then soared 69.81% in 2025.
• Over 5 years, Current Deferred Revenue stood at $31.6 million in 2022, then rose by 21.9% to $38.6 million in 2023, then retreated by 9.4% to $34.9 million in 2024, then jumped by 69.81% to $59.3 million in 2025, then increased by 9.11% to $64.7 million in 2026.
• The last three Current Deferred Revenue figures came in at $64.7 million (Q2 2026), $59.7 million (Q1 2026), and $59.3 million (Q4 2025), per Business Quant data.